These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 7741365

  • 1. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L.
    Ann Intern Med; 1995 Jun 01; 122(11):816-22. PubMed ID: 7741365
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W, Liu P, Blendis L, Wong F.
    Am J Med; 1999 Mar 01; 106(3):315-22. PubMed ID: 10190381
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
    Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M.
    Hepatology; 1998 Sep 01; 28(3):683-8. PubMed ID: 9731559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK, James PD, Sniderman KW, Wong F.
    J Gastroenterol Hepatol; 2015 Feb 01; 30(2):389-95. PubMed ID: 25168607
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.
    Am J Gastroenterol; 1997 Mar 01; 92(3):394-9. PubMed ID: 9068457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
    Geilswijk M, Thomsen KL, Pedersen EB, Vilstrup H, Grønbæk H.
    Scand J Gastroenterol; 2015 Apr 01; 50(4):454-61. PubMed ID: 25637473
    [Abstract] [Full Text] [Related]

  • 13. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
    Garcia-Tsao G.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul 01; 3(7):380-9. PubMed ID: 16819501
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK, James PD, Wong F.
    Dig Dis Sci; 2016 Oct 01; 61(10):3084-3092. PubMed ID: 27048451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.